| Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ... New England Journal of Medicine 378 (5), 439-448, 2018 | 4574 | 2018 |
| Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function B Foley, S Cooley, MR Verneris, M Pitt, J Curtsinger, X Luo, ... Blood, The Journal of the American Society of Hematology 119 (11), 2665-2674, 2012 | 707 | 2012 |
| Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation RC Lindsley, W Saber, BG Mar, R Redd, T Wang, MD Haagenson, ... New England Journal of Medicine 376 (6), 536-547, 2017 | 704 | 2017 |
| Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood CG Brunstein, JA Gutman, DJ Weisdorf, AE Woolfrey, TE DeFor, ... Blood, The Journal of the American Society of Hematology 116 (22), 4693-4699, 2010 | 581 | 2010 |
| NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17) R Romee, B Foley, T Lenvik, Y Wang, B Zhang, D Ankarlo, X Luo, ... Blood, The Journal of the American Society of Hematology 121 (18), 3599-3608, 2013 | 550 | 2013 |
| Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells MR Verneris, M Karami, J Baker, A Jayaswal, RS Negrin Blood 103 (8), 3065-3072, 2004 | 479 | 2004 |
| Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ... Nature medicine 24 (10), 1504-1506, 2018 | 469 | 2018 |
| Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein V Bachanova, S Cooley, TE Defor, MR Verneris, B Zhang, DH McKenna, ... Blood, The Journal of the American Society of Hematology 123 (25), 3855-3863, 2014 | 435 | 2014 |
| Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging M Edinger, YA Cao, MR Verneris, MH Bachmann, CH Contag, RS Negrin Blood, The Journal of the American Society of Hematology 101 (2), 640-648, 2003 | 430 | 2003 |
| Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect CG Brunstein, JS Miller, DH McKenna, KL Hippen, TE DeFor, D Sumstad, ... Blood, The Journal of the American Society of Hematology 127 (8), 1044-1051, 2016 | 409 | 2016 |
| Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand in vivo in response to recipient CMV antigen B Foley, S Cooley, MR Verneris, J Curtsinger, X Luo, EK Waller, ... The Journal of Immunology 189 (10), 5082-5088, 2012 | 407 | 2012 |
| Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9 MK Gleason, TR Lenvik, V McCullar, M Felices, MS O'Brien, SA Cooley, ... Blood, the Journal of the American Society of Hematology 119 (13), 3064-3072, 2012 | 374 | 2012 |
| Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT JS Miller, S Cooley, P Parham, SS Farag, MR Verneris, KL McQueen, ... Blood, The Journal of the American Society of Hematology 109 (11), 5058-5061, 2007 | 353 | 2007 |
| First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation R Romee, S Cooley, MM Berrien-Elliott, P Westervelt, MR Verneris, ... Blood, The Journal of the American Society of Hematology 131 (23), 2515-2527, 2018 | 350 | 2018 |
| IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced … DA Vallera, M Felices, R McElmurry, V McCullar, X Zhou, JU Schmohl, ... Clinical Cancer Research 22 (14), 3440-3450, 2016 | 350 | 2016 |
| Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units MR Verneris, CG Brunstein, J Barker, ML MacMillan, T DeFor, ... Blood, The Journal of the American Society of Hematology 114 (19), 4293-4299, 2009 | 332 | 2009 |
| One-unit versus two-unit cord-blood transplantation for hematologic cancers JE Wagner Jr, M Eapen, S Carter, Y Wang, KR Schultz, DA Wall, N Bunin, ... New England Journal of Medicine 371 (18), 1685-1694, 2014 | 314 | 2014 |
| Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production J Baker, MR Verneris, M Ito, JA Shizuru, RS Negrin Blood, The Journal of the American Society of Hematology 97 (10), 2923-2931, 2001 | 299 | 2001 |
| Advancing animal models of neoplasia through in vivo bioluminescence imaging M Edinger, YA Cao, YS Hornig, DE Jenkins, MR Verneris, MH Bachmann, ... European journal of cancer 38 (16), 2128-2136, 2002 | 291 | 2002 |
| Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity PS Woll, B Grzywacz, X Tian, RK Marcus, DA Knorr, MR Verneris, ... Blood, The Journal of the American Society of Hematology 113 (24), 6094-6101, 2009 | 281 | 2009 |
